Synergy between food and pharma driving South America's economy

4 September 2013

UBM Live announced that this year’s recent CPhI South America, which took place last month at the Expo Center Norte in Sao Paulo, Argentina, proved to be the foremost event for collaborating two integral industries and providing the opportunity to form symbiotic partnerships with industry leaders to shape the collective markets.

South America is undergoing a changing macro-economic environment, with a burgeoning middle-class and heightened job opportunities, which in turn has lead to an increased demand for healthcare and the pharmaceutical industry in general.

Dynamic growth for Brazil’s pharma market forecast

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >